USFDA issues 6 observations after inspection of Aurobindo Pharma Jedcherla plant
Aurobindo Pharma receives 6 observations after inspection of Aurobindo Pharma Jedcherla plant.
The United States Food and Drug Administration (US FDA) inspected Aurobindo Pharma's Unit VII, an oral manufacturing facility situated at Jedcherla, Hyderabad, from 2nd to 10th May 2022.